{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:48:40Z","timestamp":1793843320055,"version":"4.6.1"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2022YFC2503802"],"award-info":[{"award-number":["2022YFC2503802"]}]},{"name":"The National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases of Xiangya Hospital, Central South University","award":["z027001"],"award-info":[{"award-number":["z027001"]}]},{"name":"the Innovative Construction Foundation of Hunan Province","award":["2021SK4001"],"award-info":[{"award-number":["2021SK4001"]}]},{"name":"the National Natural Science Foundation of Hunan province, China","award":["2023JJ30924"],"award-info":[{"award-number":["2023JJ30924"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific research project of Health Commission of Hunan Province","award":["B202303076019"],"award-info":[{"award-number":["B202303076019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammation is a key pathological mechanism underlying neurodegenerative diseases, and intricately interacts with protein glycosylation. Emerging evidence suggests that aberrant glycosylation disrupts immune homeostasis, activates microglia, and promotes the release of inflammatory mediators, thereby exacerbating neuroinflammatory responses. In addition, the inflammatory microenvironment can further dysregulate glycosylation patterns, creating a vicious cycle that amplifies disease pathology. Although the regulatory role of glycosylation in neuroinflammation associated with neurodegenerative diseases has been recognized, the precise molecular and cellular mechanisms remain incompletely understood. This review systematically examines the complex crosstalk between glycosylation and neuroinflammation, with a particular focus on the critical roles of glycosylation in key neurodegenerative diseases, including Alzheimer\u2019s disease, Parkinson\u2019s disease, multiple sclerosis, and amyotrophic lateral sclerosis. We explore how glycosylation abnormalities contribute to disease pathogenesis through effects on immune recognition, protein aggregation, and cellular functions. Understanding the molecular underpinnings of these diseases may pave the way for the development of therapeutic strategies targeting glycosylation pathways, ultimately improving clinical outcomes for patients.<\/jats:p>","DOI":"10.1186\/s40035-025-00506-4","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T09:04:21Z","timestamp":1758531861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases"],"prefix":"10.1186","volume":"14","author":[{"given":"Shenglan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3189-3361","authenticated-orcid":false,"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"1","key":"506_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19(1):206.","journal-title":"J Neuroinflammation"},{"key":"506_CR2","doi-asserted-by":"crossref","unstructured":"Pajares M, A IR, Manda G, Bosc\u00e1 L, Cuadrado A. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells. 2020;9(7).","DOI":"10.3390\/cells9071687"},{"issue":"6","key":"506_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, et al. Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol. 2022;20(6):1116\u201343.","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"506_CR4","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.cell.2024.02.030","volume":"187","author":"P Kukanja","year":"2024","unstructured":"Kukanja P, Langseth CM, Rubio Rodr\u00edguez-Kirby LA, Agirre E, Zheng C, Raman A, et al. Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology. Cell. 2024;187(8):1990-2009.e19.","journal-title":"Cell"},{"issue":"2","key":"506_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"KG Hooten","year":"2015","unstructured":"Hooten KG, Beers DR, Zhao W, Appel SH. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12(2):364\u201375.","journal-title":"Neurotherapeutics"},{"key":"506_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101439","author":"JR Perea","year":"2020","unstructured":"Perea JR, Bol\u00f3s M, Avila J. Microglia in Alzheimer\u2019s disease in the context of tau pathology. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10101439.","journal-title":"Biomolecules"},{"issue":"4","key":"506_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"key":"506_CR8","unstructured":"In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al., editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press Copyright \u00a9 2009, The Consortium of Glycobiology Editors, La Jolla, California; 2009."},{"issue":"5512","key":"506_CR9","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","volume":"291","author":"PM Rudd","year":"2001","unstructured":"Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291(5512):2370\u20136.","journal-title":"Science"},{"issue":"3","key":"506_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","volume":"20","author":"BAH Smith","year":"2021","unstructured":"Smith BAH, Bertozzi CR. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans. Nat Rev Drug Discov. 2021;20(3):217\u201343.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"506_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41589-019-0350-2","volume":"15","author":"KW Moremen","year":"2019","unstructured":"Moremen KW, Haltiwanger RS. Emerging structural insights into glycosyltransferase-mediated synthesis of glycans. Nat Chem Biol. 2019;15(9):853\u201364.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"506_CR12","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/cells10082136","volume":"10","author":"C De Vellis","year":"2021","unstructured":"De Vellis C, Pietrobono S, Stecca B. The role of glycosylation in melanoma progression. Cells.\u00a02021;10(8):2136.","journal-title":"Cells"},{"issue":"10","key":"506_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/cells8101125","volume":"8","author":"SS Siddiqui","year":"2019","unstructured":"Siddiqui SS, Matar R, Merheb M, Hodeify R, Vazhappilly CG, Marton J, et al. Siglecs in brain function and neurological disorders. Cells.\u00a02019;8(10):1125.","journal-title":"Cells"},{"issue":"24","key":"506_CR14","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.3390\/molecules24244604","volume":"24","author":"W Wang","year":"2019","unstructured":"Wang W, Gopal S, Pocock R, Xiao Z. Glycan mimetics from natural products: new therapeutic opportunities for neurodegenerative disease. Molecules.\u00a02019;24(24):4604.","journal-title":"Molecules"},{"issue":"12","key":"506_CR15","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1016\/j.cell.2021.04.023","volume":"184","author":"RA Flynn","year":"2021","unstructured":"Flynn RA, Pedram K, Malaker SA, Batista PJ, Smith BAH, Johnson AG, et al. Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell. 2021;184(12):3109-24.e22.","journal-title":"Cell"},{"issue":"7628","key":"506_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539(7628):180\u20136.","journal-title":"Nature"},{"issue":"3","key":"506_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrn1349","volume":"5","author":"R Kleene","year":"2004","unstructured":"Kleene R, Schachner M. Glycans and neural cell interactions. Nat Rev Neurosci. 2004;5(3):195\u2013208.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"506_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13578-022-00751-4","volume":"12","author":"J Yang","year":"2022","unstructured":"Yang J, Yin M, Hou Y, Li H, Guo Y, Yu H, et al. Role of ammonia for brain abnormal protein glycosylation during the development of hepatitis B virus-related liver diseases. Cell Biosci. 2022;12(1):16.","journal-title":"Cell Biosci"},{"issue":"4","key":"506_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.molmed.2022.01.004","volume":"28","author":"AL Rebelo","year":"2022","unstructured":"Rebelo AL, Chevalier MT, Russo L, Pandit A. Role and therapeutic implications of protein glycosylation in neuroinflammation. Trends Mol Med. 2022;28(4):270\u201389.","journal-title":"Trends Mol Med"},{"key":"506_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/ncomms1333","volume":"2","author":"H Mkhikian","year":"2011","unstructured":"Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, et al. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun. 2011;2:334.","journal-title":"Nat Commun"},{"issue":"46","key":"506_CR21","doi-asserted-by":"publisher","first-page":"33725","DOI":"10.1074\/jbc.M704839200","volume":"282","author":"SU Lee","year":"2007","unstructured":"Lee SU, Grigorian A, Pawling J, Chen IJ, Gao G, Mozaffar T, et al. N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J Biol Chem. 2007;282(46):33725\u201334.","journal-title":"J Biol Chem"},{"issue":"7","key":"506_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1084\/jem.20122192","volume":"211","author":"JJ Garc\u00eda-Vallejo","year":"2014","unstructured":"Garc\u00eda-Vallejo JJ, Ilarregui JM, Kalay H, Chamorro S, Koning N, Unger WW, et al. CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG. J Exp Med. 2014;211(7):1465\u201383.","journal-title":"J Exp Med"},{"issue":"6","key":"506_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346\u201366.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"506_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","volume":"126","author":"K Ohtsubo","year":"2006","unstructured":"Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126(5):855\u201367.","journal-title":"Cell"},{"issue":"7","key":"506_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","volume":"13","author":"KW Moremen","year":"2012","unstructured":"Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 2012;13(7):448\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"506_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1600-065X.2009.00789.x","volume":"230","author":"WK Ip","year":"2009","unstructured":"Ip WK, Takahashi K, Ezekowitz RA, Stuart LM. Mannose-binding lectin and innate immunity. Immunol Rev. 2009;230(1):9\u201321.","journal-title":"Immunol Rev"},{"issue":"1\u20132","key":"506_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jneuroim.2011.08.018","volume":"239","author":"JY Kwok","year":"2011","unstructured":"Kwok JY, Vaida F, Augst RM, Yu DY, Singh KK. Mannose binding lectin mediated complement pathway in multiple sclerosis. J Neuroimmunol. 2011;239(1\u20132):98\u2013100.","journal-title":"J Neuroimmunol"},{"key":"506_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0404.2006.00619.x","volume":"183","author":"O Torkildsen","year":"2006","unstructured":"Torkildsen O, Vedeler CA, Nyland HI, Myhr KM. FcgammaR and multiple sclerosis: an overview. Acta Neurol Scand Suppl. 2006;183:61\u20133.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"2 Suppl 2","key":"506_CR29","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder Jr","year":"2010","unstructured":"Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41-52.","journal-title":"J Allergy Clin Immunol"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","volume":"25","author":"JN Arnold","year":"2007","unstructured":"Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21\u201350.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"506_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151(1):42\u201350.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"506_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/antib2030392","volume":"2","author":"K-TC Shade","year":"2013","unstructured":"Shade K-TC, Anthony RM. Antibody glycosylation and inflammation. Antibodies (Basel). 2013;2(3):392\u2013414.","journal-title":"Antibodies (Basel)"},{"key":"506_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","volume":"12","author":"M Wuhrer","year":"2015","unstructured":"Wuhrer M, Selman MH, McDonnell LA, K\u00fcmpfel T, Derfuss T, Khademi M, et al. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J Neuroinflammation. 2015;12:235.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"506_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11481-021-09996-1","volume":"17","author":"PGE Kennedy","year":"2022","unstructured":"Kennedy PGE, Graner M, Pointon T, Li X, Tanimoto K, Dennison K, et al. Aberrant immunoglobulin G glycosylation in multiple sclerosis. J Neuroimmune Pharmacol. 2022;17(1\u20132):218\u201327.","journal-title":"J Neuroimmune Pharmacol"},{"key":"506_CR35","doi-asserted-by":"crossref","unstructured":"Anderson K, Evers D, Rice KG. Structure and Function of Mammalian Carbohydrate-Lectin Interactions. In: Fraser-Reid BO, Tatsuta K, Thiem J, editors. Glycoscience: Chemistry and Chemical Biology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 2445\u201382.","DOI":"10.1007\/978-3-540-30429-6_63"},{"issue":"31","key":"506_CR36","doi-asserted-by":"publisher","first-page":"28939","DOI":"10.1074\/jbc.M104565200","volume":"276","author":"DA Mitchell","year":"2001","unstructured":"Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem. 2001;276(31):28939\u201345.","journal-title":"J Biol Chem"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbi.2019.10.015","volume":"83","author":"Y Li","year":"2020","unstructured":"Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, et al. Galectin-1 attenuates neurodegeneration in Parkinson\u2019s disease model by modulating microglial MAPK\/I\u03baB\/NF\u03baB axis through its carbohydrate-recognition domain. Brain Behav Immun. 2020;83:214\u201325.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"506_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","volume":"37","author":"SC Starossom","year":"2012","unstructured":"Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity. 2012;37(2):249\u201363.","journal-title":"Immunity"},{"issue":"8","key":"506_CR39","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ni1482","volume":"8","author":"MA Toscano","year":"2007","unstructured":"Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 2007;8(8):825\u201334.","journal-title":"Nat Immunol"},{"key":"506_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-32","volume":"7","author":"C Venkatesan","year":"2010","unstructured":"Venkatesan C, Chrzaszcz M, Choi N, Wainwright MS. Chronic upregulation of activated microglia immunoreactive for galectin-3\/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflammation. 2010;7: 32.","journal-title":"J Neuroinflammation"},{"key":"506_CR41","first-page":"156","volume":"2","author":"A Boza-Serrano","year":"2014","unstructured":"Boza-Serrano A, Reyes JF, Rey NL, Leffler H, Bousset L, Nilsson U, et al. The role of Galectin-3 in \u03b1-synuclein-induced microglial activation. Acta Neuropathol Commun. 2014;2:156.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"506_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/ecco-jcc\/jjw013","volume":"10","author":"B Simovic Markovic","year":"2016","unstructured":"Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, et al. Galectin-3 plays an important pro-inflammatory role in the induction phase of acute colitis by promoting activation of NLRP3 inflammasome and production of IL-1\u03b2 in macrophages. J Crohns Colitis. 2016;10(5):593\u2013606.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"506_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/03009742.2021.1992860","volume":"52","author":"MA Nielsen","year":"2023","unstructured":"Nielsen MA, K\u00f8ster D, Greisen S, Troldborg A, Stengaard-Pedersen K, Junker P, et al. Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis. Scand J Rheumatol. 2023;52(1):33\u201341.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"506_CR44","first-page":"476","volume":"23","author":"M Mahalleh","year":"2024","unstructured":"Mahalleh M, Behnoush AH, Khalaji A, Gouravani M, Assempoor R, Jamshidi A, et al. Serum Galectin-3 level in patients with rheumatoid arthritis: a systematic review and meta-analysis. Iran J Allergy Asthma Immunol. 2024;23(5):476\u201388.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"5","key":"506_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.17219\/acem\/204107","volume":"34","author":"B Olejnik","year":"2025","unstructured":"Olejnik B, Ferens-Sieczkowska M. Lectins and neurodegeneration: a glycobiologist\u2019s perspective. Adv Clin Exp Med. 2025;34(5):673\u20139.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"506_CR46","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun. 2019;10(1):3473.","journal-title":"Nat Commun"},{"issue":"10","key":"506_CR47","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1523\/JNEUROSCI.5360-06.2007","volume":"27","author":"M Lalancette-H\u00e9bert","year":"2007","unstructured":"Lalancette-H\u00e9bert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci. 2007;27(10):2596\u2013605.","journal-title":"J Neurosci"},{"issue":"9","key":"506_CR48","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1007\/s12035-019-1527-0","volume":"56","author":"R Rahimian","year":"2019","unstructured":"Rahimian R, Lively S, Abdelhamid E, Lalancette-Hebert M, Schlichter L, Sato S, et al. Delayed galectin-3-mediated reprogramming of microglia after stroke is protective. Mol Neurobiol. 2019;56(9):6371\u201385.","journal-title":"Mol Neurobiol"},{"issue":"30","key":"506_CR49","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1523\/JNEUROSCI.1498-12.2012","volume":"32","author":"M Lalancette-H\u00e9bert","year":"2012","unstructured":"Lalancette-H\u00e9bert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, et al. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci. 2012;32(30):10383\u201395.","journal-title":"J Neurosci"},{"issue":"5","key":"506_CR50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000517687","volume":"43","author":"K S\u00e4vman","year":"2021","unstructured":"S\u00e4vman K, Wang W, Rafati AH, Svedin P, Nair S, Golubinskaya V, et al. Galectin-3 modulates microglia inflammation in vitro but not neonatal brain injury in vivo under inflammatory conditions. Dev Neurosci. 2021;43(5):296\u2013311.","journal-title":"Dev Neurosci"},{"issue":"5","key":"506_CR51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/brb3.75","volume":"2","author":"BJ Lerman","year":"2012","unstructured":"Lerman BJ, Hoffman EP, Sutherland ML, Bouri K, Hsu DK, Liu FT, et al. Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Brain Behav. 2012;2(5):563\u201375.","journal-title":"Brain Behav"},{"key":"506_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-014-0144-0","volume":"11","author":"AJ Steelman","year":"2014","unstructured":"Steelman AJ, Li J. Astrocyte galectin-9 potentiates microglial TNF secretion. J Neuroinflammation. 2014;11:144.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"506_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130772","volume":"10","author":"JF Sampson","year":"2015","unstructured":"Sampson JF, Hasegawa E, Mulki L, Suryawanshi A, Jiang S, Chen WS, et al. Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response. PLoS One. 2015;10(6): e0130772.","journal-title":"PLoS One"},{"issue":"12","key":"506_CR54","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6(12):1245\u201352.","journal-title":"Nat Immunol"},{"issue":"8","key":"506_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0167-7799(97)01060-3","volume":"15","author":"LD Shultz","year":"1997","unstructured":"Shultz LD, Rajan TV, Greiner DL. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 1997;15(8):302\u20137.","journal-title":"Trends Biotechnol"},{"issue":"4","key":"506_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7(4):255\u201366.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"506_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cytogfr.2014.02.003","volume":"25","author":"SP Mendez-Huergo","year":"2014","unstructured":"Mendez-Huergo SP, Maller SM, Farez MF, Mari\u00f1o K, Correale J, Rabinovich GA. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation. Cytokine Growth Factor Rev. 2014;25(3):247\u201355.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"506_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens6040060","volume":"6","author":"NA Mabbott","year":"2017","unstructured":"Mabbott NA. How do PrP(Sc) prions spread between host species, and within hosts? Pathogens. 2017;6(4): 60.","journal-title":"Pathogens"},{"issue":"10","key":"506_CR59","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.4049\/jimmunol.0804247","volume":"182","author":"C Wu","year":"2009","unstructured":"Wu C, Rauch U, Korpos E, Song J, Loser K, Crocker PR, et al. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol. 2009;182(10):6508\u201316.","journal-title":"J Immunol"},{"key":"506_CR60","volume":"2","author":"J Jellusova","year":"2011","unstructured":"Jellusova J, Nitschke L. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol. 2011;2: 96.","journal-title":"Front Immunol"},{"issue":"4","key":"506_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/glia.20009","volume":"46","author":"RT Mott","year":"2004","unstructured":"Mott RT, Ait-Ghezala G, Town T, Mori T, Vendrame M, Zeng J, et al. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia. 2004;46(4):369\u201379.","journal-title":"Glia"},{"issue":"5","key":"506_CR62","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, et al. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103(5):820-35.e7.","journal-title":"Neuron"},{"key":"506_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00158","volume":"11","author":"JJ Siew","year":"2018","unstructured":"Siew JJ, Chern Y. Microglial lectins in health and neurological diseases. Front Mol Neurosci. 2018;11: 158.","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"506_CR64","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1523\/JNEUROSCI.3940-09.2010","volume":"30","author":"Y Wang","year":"2010","unstructured":"Wang Y, Neumann H. Alleviation of neurotoxicity by microglial human Siglec-11. J Neurosci. 2010;30(9):3482\u20138.","journal-title":"J Neurosci"},{"key":"506_CR65","doi-asserted-by":"crossref","unstructured":"Linnartz B, Wang Y, Neumann H. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation. Int J Alzheimers Dis. 2010;2010.","DOI":"10.4061\/2010\/587463"},{"issue":"2","key":"506_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/cells9020383","volume":"9","author":"YN Paudel","year":"2020","unstructured":"Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF. Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting. Cells.\u00a02020;9(2):383.","journal-title":"Cells"},{"key":"506_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2018.02.049","volume":"672","author":"X Jiang","year":"2018","unstructured":"Jiang X, Wang X, Tuo M, Ma J, Xie A. RAGE and its emerging role in the pathogenesis of Parkinson\u2019s disease. Neurosci Lett. 2018;672:65\u20139.","journal-title":"Neurosci Lett"},{"issue":"1","key":"506_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12974-023-02824-8","volume":"20","author":"X Dong","year":"2023","unstructured":"Dong X, Shu L, Zhang J, Yang X, Cheng X, Zhao X, et al. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-\u03baB signaling pathway. J Neuroinflammation. 2023;20(1):146.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"506_CR69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","volume":"328","author":"WM Chu","year":"2013","unstructured":"Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328(2):222\u20135.","journal-title":"Cancer Lett"},{"issue":"6","key":"506_CR70","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF, Sepulveda J, Kopetsky G, Rebeck GW. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia. 2021;69(6):1478\u201393.","journal-title":"Glia"},{"issue":"2","key":"506_CR71","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","volume":"111","author":"M Gratuze","year":"2023","unstructured":"Gratuze M, Schlachetzki JCM, D\u2019Oliveira Albanus R, Jain N, Novotny B, Brase L, et al. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Neuron. 2023;111(2):202-19.e7.","journal-title":"Neuron"},{"issue":"12","key":"506_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052975","volume":"7","author":"C Chen","year":"2012","unstructured":"Chen C, Diao D, Guo L, Shi M, Gao J, Hu M, et al. All-trans-retinoic acid modulates ICAM-1 N-glycan composition by influencing gnt-iii levels and inhibits cell adhesion and trans-endothelial migration. PLoS One. 2012;7(12): e52975.","journal-title":"PLoS One"},{"key":"506_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fncel.2019.00337","volume":"13","author":"SF Spampinato","year":"2019","unstructured":"Spampinato SF, Merlo S, Fagone E, Fruciano M, Barbagallo C, Kanda T, et al. Astrocytes modify migration of PBMCs induced by \u03b2-amyloid in a blood-brain barrier in vitro model. Front Cell Neurosci.\u00a02019:13:337.","journal-title":"Front Cell Neurosci"},{"issue":"13","key":"506_CR74","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1039\/D1CS00991E","volume":"51","author":"T Bilbrough","year":"2022","unstructured":"Bilbrough T, Piemontese E, Seitz O. Dissecting the role of protein phosphorylation: a chemical biology toolbox. Chem Soc Rev. 2022;51(13):5691\u2013730.","journal-title":"Chem Soc Rev"},{"issue":"29","key":"506_CR75","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","volume":"101","author":"F Liu","year":"2004","unstructured":"Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(29):10804\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"506_CR76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nchem.2361","volume":"7","author":"NP Marotta","year":"2015","unstructured":"Marotta NP, Lin YH, Lewis YE, Ambroso MR, Zaro BW, Roth MT, et al. O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with Parkinson\u2019s disease. Nat Chem. 2015;7(11):913\u201320.","journal-title":"Nat Chem"},{"issue":"6","key":"506_CR77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/tra.12392","volume":"17","author":"L Ellgaard","year":"2016","unstructured":"Ellgaard L, McCaul N, Chatsisvili A, Braakman I. Co- and post-translational protein folding in the ER. Traffic. 2016;17(6):615\u201338.","journal-title":"Traffic"},{"key":"506_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","volume":"226","author":"IM Ibrahim","year":"2019","unstructured":"Ibrahim IM, Abdelmalek DH, Elfiky AA. GRP78: A cell\u2019s response to stress. Life Sci. 2019;226:156\u201363.","journal-title":"Life Sci"},{"issue":"3","key":"506_CR79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbrc.2020.09.024","volume":"533","author":"F Fan","year":"2020","unstructured":"Fan F, Zhang Q, Lu D. Identification of N-glycosylation sites on AtERO1 and AtERO2 using a transient expression system. Biochem Biophys Res Commun. 2020;533(3):481\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"506_CR80","doi-asserted-by":"publisher","first-page":"C651","DOI":"10.1152\/ajpcell.00195.2016","volume":"312","author":"TD Ostrowski","year":"2017","unstructured":"Ostrowski TD, Dantzler HA, Polo-Parada L, Kline DD. H(2)O(2) augments cytosolic calcium in nucleus tractus solitarii neurons via multiple voltage-gated calcium channels. Am J Physiol Cell Physiol. 2017;312(5):C651\u201362.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"506_CR81","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/135100005X21660","volume":"10","author":"Y Zheng","year":"2005","unstructured":"Zheng Y, Shen X. H2O2 directly activates inositol 1,4,5-trisphosphate receptors in endothelial cells. Redox Rep. 2005;10(1):29\u201336.","journal-title":"Redox Rep"},{"key":"506_CR82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2017.03.005","volume":"307","author":"Y Dong","year":"2017","unstructured":"Dong Y, Kalueff AV, Song C. N-methyl-d-aspartate receptor-mediated calcium overload and endoplasmic reticulum stress are involved in interleukin-1beta-induced neuronal apoptosis in rat hippocampus. J Neuroimmunol. 2017;307:7\u201313.","journal-title":"J Neuroimmunol"},{"key":"506_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuint.2017.10.003","volume":"117","author":"A Andreyev","year":"2018","unstructured":"Andreyev A, Tamrakar P, Rosenthal RE, Fiskum G. Calcium uptake and cytochrome c release from normal and ischemic brain mitochondria. Neurochem Int. 2018;117:15\u201322.","journal-title":"Neurochem Int"},{"issue":"5","key":"506_CR84","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.molcel.2019.03.031","volume":"74","author":"E Balsa","year":"2019","unstructured":"Balsa E, Soustek MS, Thomas A, Cogliati S, Garc\u00eda-Poyatos C, Mart\u00edn-Garc\u00eda E, et al. ER and nutrient stress promote assembly of respiratory chain supercomplexes through the PERK-eIF2\u03b1 Axis. Mol Cell. 2019;74(5):877-90.e6.","journal-title":"Mol Cell"},{"issue":"5","key":"506_CR85","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-015-1487-z","volume":"130","author":"H Radford","year":"2015","unstructured":"Radford H, Moreno JA, Verity N, Halliday M, Mallucci GR. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol. 2015;130(5):633\u201342.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"506_CR86","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.cell.2014.07.001","volume":"158","author":"J Baleriola","year":"2014","unstructured":"Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, et al. Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell. 2014;158(5):1159\u201372.","journal-title":"Cell"},{"key":"506_CR87","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clim.2016.09.014","volume":"189","author":"Z Yan","year":"2018","unstructured":"Yan Z, Gibson SA, Buckley JA, Qin H, Benveniste EN. Role of the JAK\/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol. 2018;189:4\u201313.","journal-title":"Clin Immunol"},{"issue":"11","key":"506_CR88","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20(11):1242\u201353.","journal-title":"Nat Med"},{"key":"506_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155518","volume":"128","author":"W Wang","year":"2024","unstructured":"Wang W, Wang Y, Wang F, Xie G, Liu S, Li Z, et al. Gastrodin regulates the TLR4\/TRAF6\/NF-\u03baB pathway to reduce neuroinflammation and microglial activation in an AD model. Phytomedicine. 2024;128: 155518.","journal-title":"Phytomedicine"},{"key":"506_CR90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2013.06.002","volume":"106\u2013107","author":"A Salminen","year":"2013","unstructured":"Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, et al. Impaired autophagy and APP processing in Alzheimer\u2019s disease: The potential role of Beclin 1 interactome. Prog Neurobiol. 2013;106\u2013107:33\u201354.","journal-title":"Prog Neurobiol"},{"issue":"12","key":"506_CR91","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1021\/ja300094r","volume":"134","author":"F Meier","year":"2012","unstructured":"Meier F, Abeywardana T, Dhall A, Marotta NP, Varkey J, Langen R, et al. Semisynthetic, site-specific ubiquitin modification of \u03b1-synuclein reveals differential effects on aggregation. J Am Chem Soc. 2012;134(12):5468\u201371.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"506_CR92","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ceb.2011.05.007","volume":"23","author":"M Karbowski","year":"2011","unstructured":"Karbowski M, Youle RJ. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr Opin Cell Biol. 2011;23(4):476\u201382.","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"506_CR93","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.molcel.2013.01.036","volume":"49","author":"AK M\u00fcller-Rischart","year":"2013","unstructured":"M\u00fcller-Rischart AK, Pilsl A, Beaudette P, Patra M, Hadian K, Funke M, et al. The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell. 2013;49(5):908\u201321.","journal-title":"Mol Cell"},{"issue":"3","key":"506_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004973","volume":"4","author":"J Lagirand-Cantaloube","year":"2009","unstructured":"Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA. Inhibition of atrogin-1\/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One. 2009;4(3): e4973.","journal-title":"PLoS One"},{"issue":"4","key":"506_CR95","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1083\/jcb.201110067","volume":"198","author":"S Cohen","year":"2012","unstructured":"Cohen S, Zhai B, Gygi SP, Goldberg AL. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J Cell Biol. 2012;198(4):575\u201389.","journal-title":"J Cell Biol"},{"issue":"2","key":"506_CR96","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1074\/jbc.M112.399949","volume":"288","author":"PN Quy","year":"2013","unstructured":"Quy PN, Kuma A, Pierre P, Mizushima N. Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation. J Biol Chem. 2013;288(2):1125\u201334.","journal-title":"J Biol Chem"},{"issue":"51","key":"506_CR97","doi-asserted-by":"publisher","first-page":"39597","DOI":"10.1074\/jbc.M110.129718","volume":"285","author":"M Altun","year":"2010","unstructured":"Altun M, Besche HC, Overkleeft HS, Piccirillo R, Edelmann MJ, Kessler BM, et al. Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J Biol Chem. 2010;285(51):39597\u2013608.","journal-title":"J Biol Chem"},{"issue":"6","key":"506_CR98","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0092-8674(03)00974-7","volume":"115","author":"F Zhang","year":"2003","unstructured":"Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell. 2003;115(6):715\u201325.","journal-title":"Cell"},{"issue":"10","key":"506_CR99","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb1470","volume":"8","author":"WH Yang","year":"2006","unstructured":"Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol. 2006;8(10):1074\u201383.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"506_CR100","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.febslet.2008.12.007","volume":"583","author":"K Lim","year":"2009","unstructured":"Lim K, Chang HI. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. FEBS Lett. 2009;583(3):512\u201320.","journal-title":"FEBS Lett"},{"issue":"8","key":"506_CR101","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1096\/fj.07-102509","volume":"22","author":"C Guinez","year":"2008","unstructured":"Guinez C, Mir AM, Dehennaut V, Cacan R, Harduin-Lepers A, Michalski JC, et al. Protein ubiquitination is modulated by O-GlcNAc glycosylation. Faseb j. 2008;22(8):2901\u201311.","journal-title":"Faseb j"},{"issue":"20","key":"506_CR102","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1073\/pnas.1102458108","volume":"108","author":"BW Zaro","year":"2011","unstructured":"Zaro BW, Yang YY, Hang HC, Pratt MR. Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc Natl Acad Sci U S A. 2011;108(20):8146\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"506_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00569-5","volume":"13","author":"K Sun","year":"2024","unstructured":"Sun K, Zhi Y, Ren W, Li S, Zheng J, Gao L, et al. Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance. Exp Hematol Oncol. 2024;13(1): 107.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"506_CR104","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2008.07.109","volume":"374","author":"YQ Zhang","year":"2008","unstructured":"Zhang YQ, Sarge KD. Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochem Biophys Res Commun. 2008;374(4):673\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5528","key":"506_CR105","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1060627","volume":"293","author":"H Shimura","year":"2001","unstructured":"Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson\u2019s disease. Science. 2001;293(5528):263\u20139.","journal-title":"Science"},{"issue":"11","key":"506_CR106","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1021\/acscentsci.3c01066","volume":"9","author":"CS Delaveris","year":"2023","unstructured":"Delaveris CS, Wang CL, Riley NM, Li S, Kulkarni RU, Bertozzi CR. Microglia mediate contact-independent neuronal network remodeling via secreted neuraminidase-3 associated with extracellular vesicles. ACS Cent Sci. 2023;9(11):2108\u201314.","journal-title":"ACS Cent Sci"},{"key":"506_CR107","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"506_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1): 42.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"506_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1313-3","volume":"15","author":"EA Newcombe","year":"2018","unstructured":"Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R. Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease. J Neuroinflammation. 2018;15(1): 276.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"506_CR110","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","volume":"34","author":"A Griciuc","year":"2021","unstructured":"Griciuc A, Tanzi RE. The role of innate immune genes in Alzheimer\u2019s disease. Curr Opin Neurol. 2021;34(2):228\u201336.","journal-title":"Curr Opin Neurol"},{"key":"506_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-171","volume":"8","author":"JJ Hoozemans","year":"2011","unstructured":"Hoozemans JJ, Rozemuller AJ, van Haastert ES, Eikelenboom P, van Gool WA. Neuroinflammation in Alzheimer\u2019s disease wanes with age. J Neuroinflammation. 2011;8: 171.","journal-title":"J Neuroinflammation"},{"key":"506_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101417","volume":"70","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Yu WS, Lim LW. Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer\u2019s disease. Ageing Res Rev. 2021;70: 101417.","journal-title":"Ageing Res Rev"},{"key":"506_CR113","unstructured":"Liu PP, Xie Y, Meng XY, Kang JA-O. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. (2059\u20133635 (Electronic))."},{"key":"506_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"H Haukedal","year":"2020","unstructured":"Haukedal H, Freude KK. Implications of glycosylation in Alzheimer\u2019s disease. Front Neurosci. 2020;14: 625348.","journal-title":"Front Neurosci"},{"issue":"1","key":"506_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/glycob\/cwp152","volume":"20","author":"K Akasaka-Manya","year":"2010","unstructured":"Akasaka-Manya K, Manya H, Sakurai Y, Wojczyk BS, Kozutsumi Y, Saito Y, et al. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer\u2019s disease. Glycobiology. 2010;20(1):99\u2013106.","journal-title":"Glycobiology"},{"issue":"1","key":"506_CR116","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0197-4580(94)90149-X","volume":"15","author":"TM Maguire","year":"1994","unstructured":"Maguire TM, Gillian AM, O\u2019Mahony D, Coughlan CM, Dennihan A, Breen KC. A decrease in serum sialyltransferase levels in Alzheimer\u2019s disease. Neurobiol Aging. 1994;15(1):99\u2013102.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"506_CR117","first-page":"185","volume":"6","author":"TM Maguire","year":"1995","unstructured":"Maguire TM, Breen KC. A decrease in neural sialyltransferase activity in Alzheimer\u2019s disease. Dementia. 1995;6(4):185\u201390.","journal-title":"Dementia"},{"issue":"5","key":"506_CR118","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1046\/j.1471-4159.2001.00640.x","volume":"79","author":"LR Fodero","year":"2001","unstructured":"Fodero LR, S\u00e1ez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer\u2019s disease cerebrospinal fluid. J Neurochem. 2001;79(5):1022\u20136.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"506_CR119","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0169-328X(93)90164-K","volume":"19","author":"F Saito","year":"1993","unstructured":"Saito F, Yanagisawa K, Miyatake T. Soluble derivatives of beta\/A4 amyloid protein precursor in human cerebrospinal fluid are both N- and O-glycosylated. Brain Res Mol Brain Res. 1993;19(1\u20132):171\u20134.","journal-title":"Brain Res Mol Brain Res"},{"issue":"4","key":"506_CR120","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1471-4159.2005.03595.x","volume":"96","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Kitazume S, Oka R, Maruyama K, Saido TC, Sato Y, et al. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. J Neurochem. 2006;96(4):924\u201333.","journal-title":"J Neurochem"},{"issue":"10","key":"506_CR121","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","volume":"1861","author":"Y Kizuka","year":"2017","unstructured":"Kizuka Y, Kitazume S, Taniguchi N. N-glycan and Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA). 2017;1861(10):2447\u201354.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"506_CR122","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/glycob\/cwac009","volume":"32","author":"T Lin","year":"2022","unstructured":"Lin T, van Husen LS, Yu Y, Tjernberg LO, Schedin-Weiss S. Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein. Glycobiology. 2022;32(6):506\u201317.","journal-title":"Glycobiology"},{"issue":"2","key":"506_CR123","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/pr800758g","volume":"8","author":"I Perdivara","year":"2009","unstructured":"Perdivara I, Petrovich R, Allinquant B, Deterding LJ, Tomer KB, Przybylski M. Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation. J Proteome Res. 2009;8(2):631\u201342.","journal-title":"J Proteome Res"},{"issue":"29","key":"506_CR124","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.1102664108","volume":"108","author":"A Halim","year":"2011","unstructured":"Halim A, Brinkmalm G, R\u00fcetschi U, Westman-Brinkmalm A, Portelius E, Zetterberg H, et al. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A. 2011;108(29):11848\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"506_CR125","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jnr.490410214","volume":"41","author":"LS Griffith","year":"1995","unstructured":"Griffith LS, Mathes M, Schmitz B. Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J Neurosci Res. 1995;41(2):270\u20138.","journal-title":"J Neurosci Res"},{"issue":"1","key":"506_CR126","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-140096","volume":"44","author":"YS Chun","year":"2015","unstructured":"Chun YS, Park Y, Oh HG, Kim TW, Yang HO, Park MK, et al. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-\u03b2 protein precursor via inhibition of endocytosis from the plasma membrane. J Alzheimers Dis. 2015;44(1):261\u201375.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"506_CR127","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neurobiolaging.2012.03.001","volume":"34","author":"C Kim","year":"2013","unstructured":"Kim C, Nam DW, Park SY, Song H, Hong HS, Boo JH, et al. O-linked \u03b2-N-acetylglucosaminidase inhibitor attenuates \u03b2-amyloid plaque and rescues memory impairment. Neurobiol Aging. 2013;34(1):275\u201385.","journal-title":"Neurobiol Aging"},{"key":"506_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-42","volume":"9","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Shan X, Jones BA, Zhao G, Woodward ML, Li X, et al. Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau\/APP mutant mice. Mol Neurodegener. 2014;9: 42.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"506_CR129","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","volume":"404","author":"KT Jacobsen","year":"2011","unstructured":"Jacobsen KT, Iverfeldt K. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-\u03b2 precursor protein (APP). Biochem Biophys Res Commun. 2011;404(3):882\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"506_CR130","doi-asserted-by":"crossref","unstructured":"Liang C, Yuan Z, Yang S, Zhu Y, Chen Z, Can D, et al. Mannose Promotes \u03b2-Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer\u2019s Disease. Adv Sci. 2025:e2409105.","DOI":"10.1002\/advs.202409105"},{"issue":"1","key":"506_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BJ20150607","volume":"473","author":"Y Kizuka","year":"2016","unstructured":"Kizuka Y, Nakano M, Kitazume S, Saito T, Saido TC, Taniguchi N. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions. Biochem J. 2016;473(1):21\u201330.","journal-title":"Biochem J"},{"issue":"1","key":"506_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"506_CR133","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1111\/j.1460-9568.2006.04735.x","volume":"23","author":"X Li","year":"2006","unstructured":"Li X, Lu F, Wang JZ, Gong CX. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci. 2006;23(8):2078\u201386.","journal-title":"Eur J Neurosci"},{"key":"506_CR134","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.phrs.2016.01.006","volume":"105","author":"E Gatta","year":"2016","unstructured":"Gatta E, Lefebvre T, Gaetani S, dos Santos M, Marrocco J, Mir AM, et al. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer\u2019s disease. Pharmacol Res. 2016;105:186\u201397.","journal-title":"Pharmacol Res"},{"issue":"2","key":"506_CR135","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-4165(02)00477-4","volume":"1619","author":"T Lefebvre","year":"2003","unstructured":"Lefebvre T, Ferreira S, Dupont-Wallois L, Bussi\u00e8re T, Dupire MJ, Delacourte A, et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins\u2013a role in nuclear localization. Biochim Biophys Acta. 2003;1619(2):167\u201376.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"506_CR136","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/MCB.24.4.1680-1690.2004","volume":"24","author":"N O'Donnell","year":"2004","unstructured":"O\u2019Donnell N, Zachara NE, Hart GW, Marth JD. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol. 2004;24(4):1680\u201390.","journal-title":"Mol Cell Biol"},{"issue":"50","key":"506_CR137","doi-asserted-by":"publisher","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","volume":"289","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ. The emerging link between O-GlcNAc and Alzheimer disease. J Biol Chem. 2014;289(50):34472\u201381.","journal-title":"J Biol Chem"},{"issue":"5","key":"506_CR138","doi-asserted-by":"publisher","first-page":"135","DOI":"10.31083\/j.jin2205135","volume":"22","author":"N Rostgaard","year":"2023","unstructured":"Rostgaard N, Jul PH, Garmer M, Volbracht C. Increasing O-GlcNAcylation attenuates tau hyperphosphorylation and behavioral impairment in rTg4510 tauopathy mice. J Integr Neurosci. 2023;22(5):135.","journal-title":"J Integr Neurosci"},{"issue":"2","key":"506_CR139","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/187152710791012071","volume":"9","author":"S Mandrekar-Colucci","year":"2010","unstructured":"Mandrekar-Colucci S, Landreth GE. Microglia and inflammation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets. 2010;9(2):156\u201367.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"9","key":"506_CR140","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"506_CR141","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-018-1148-y","volume":"15","author":"JT Li","year":"2018","unstructured":"Li JT, Zhang Y. TREM2 regulates innate immunity in Alzheimer\u2019s disease. J Neuroinflammation. 2018;15(1):107.","journal-title":"J Neuroinflammation"},{"issue":"22","key":"506_CR142","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185(22):4153-69.e19.","journal-title":"Cell"},{"key":"506_CR143","volume":"10","author":"JS Park","year":"2016","unstructured":"Park JS, Ji IJ, Kim DH, An HJ, Yoon SY. The Alzheimer\u2019s disease-associated R47H variant of TREM2 has an altered glycosylation pattern and protein stability. Front Neurosci. 2016;10: 618.","journal-title":"Front Neurosci"},{"issue":"27","key":"506_CR144","doi-asserted-by":"publisher","first-page":"20664","DOI":"10.1074\/jbc.M109.055608","volume":"285","author":"S Ullrich","year":"2010","unstructured":"Ullrich S, M\u00fcnch A, Neumann S, Kremmer E, Tatzelt J, Lichtenthaler SF. The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein. J Biol Chem. 2010;285(27):20664\u201374.","journal-title":"J Biol Chem"},{"issue":"25","key":"506_CR145","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1523\/JNEUROSCI.1644-21.2022","volume":"42","author":"J Meng","year":"2022","unstructured":"Meng J, Han L, Zheng N, Wang T, Xu H, Jiang Y, et al. Microglial Tmem59 deficiency impairs phagocytosis of synapse and leads to autism-like behaviors in mice. J Neurosci. 2022;42(25):4958\u201379.","journal-title":"J Neurosci"},{"issue":"8","key":"506_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02874-3","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu Z, Ning J, Zheng X, Meng J, Han L, Zheng H, et al. TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities. Cell Death Dis. 2020;11(8): 678.","journal-title":"Cell Death Dis"},{"issue":"1","key":"506_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer\u2019s disease. Genome Med. 2023;15(1): 6.","journal-title":"Genome Med"},{"issue":"6","key":"506_CR148","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4103\/1673-5374.385854","volume":"19","author":"A Huo","year":"2024","unstructured":"Huo A, Wang J, Li Q, Li M, Qi Y, Yin Q, et al. Molecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning. Neural Regen Res. 2024;19(6):1284\u201390.","journal-title":"Neural Regen Res"},{"issue":"5","key":"506_CR149","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/glia.23757","volume":"68","author":"DH Allendorf","year":"2020","unstructured":"Allendorf DH, Puigdell\u00edvol M, Brown GC. Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons. Glia. 2020;68(5):989\u201398.","journal-title":"Glia"},{"issue":"2","key":"506_CR150","first-page":"599","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q, Zheng S, Soh A, Zheng Y, et al. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int J Mol Med. 2018;41(2):599\u2013614.","journal-title":"Int J Mol Med"},{"key":"506_CR151","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fncel.2020.00162","volume":"14","author":"M Puigdell\u00edvol","year":"2020","unstructured":"Puigdell\u00edvol M, Allendorf DH, Brown GC. Sialylation and galectin-3 in microglia-mediated neuroinflammation and neurodegeneration. Front Cell Neurosci. 2020;14:162.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"506_CR152","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584\u201393.","journal-title":"Nat Neurosci"},{"issue":"3","key":"506_CR153","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3233\/JAD-160371","volume":"54","author":"S Baker","year":"2016","unstructured":"Baker S, Polanco JC, G\u00f6tz J. Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice. J Alzheimers Dis. 2016;54(3):1207\u201317.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"506_CR154","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-131088","volume":"38","author":"SL Lundstr\u00f6m","year":"2014","unstructured":"Lundstr\u00f6m SL, Yang H, Lyutvinskiy Y, Rutishauser D, Herukka SK, Soininen H, et al. Blood plasma IgG Fc glycans are significantly altered in Alzheimer\u2019s disease and progressive mild cognitive impairment. J Alzheimers Dis. 2014;38(3):567\u201379.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"506_CR155","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JPD-130216","volume":"3","author":"P Wales","year":"2013","unstructured":"Wales P, Pinho R, L\u00e1zaro DF, Outeiro TF. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. J Parkinsons Dis. 2013;3(4):415\u201359.","journal-title":"J Parkinsons Dis"},{"issue":"3\u20134","key":"506_CR156","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","volume":"20","author":"G M\u00fcnch","year":"2000","unstructured":"M\u00fcnch G, L\u00fcth HJ, Wong A, Arendt T, Hirsch E, Ravid R, et al. Crosslinking of alpha-synuclein by advanced glycation endproducts\u2013an early pathophysiological step in Lewy body formation? J Chem Neuroanat. 2000;20(3\u20134):253\u20137.","journal-title":"J Chem Neuroanat"},{"issue":"5","key":"506_CR157","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awx056","volume":"140","author":"H Vicente Miranda","year":"2017","unstructured":"Vicente Miranda H, Szego \u00c9M, Oliveira LMA, Breda C, Darendelioglu E, de Oliveira RM, et al. Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies. Brain. 2017;140(5):1399\u2013419.","journal-title":"Brain"},{"issue":"1","key":"506_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44732-2","volume":"15","author":"G Morrone Parfitt","year":"2024","unstructured":"Morrone Parfitt G, Coccia E, Goldman C, Whitney K, Reyes R, Sarrafha L, et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson\u2019s disease model. Nat Commun. 2024;15(1): 447.","journal-title":"Nat Commun"},{"issue":"12","key":"506_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111401","volume":"40","author":"H Long","year":"2022","unstructured":"Long H, Zhang S, Zeng S, Tong Y, Liu J, Liu C, et al. Interaction of RAGE with \u03b1-synuclein fibrils mediates inflammatory response of microglia. Cell Rep. 2022;40(12): 111401.","journal-title":"Cell Rep"},{"issue":"4","key":"506_CR160","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol. 2021;141(4):527\u201345.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"506_CR161","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/glia.20691","volume":"56","author":"JY Park","year":"2008","unstructured":"Park JY, Paik SR, Jou I, Park SM. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson\u2019s disease. Glia. 2008;56(11):1215\u201323.","journal-title":"Glia"},{"key":"506_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02253","volume":"10","author":"J Folke","year":"2019","unstructured":"Folke J, Rydbirk R, L\u00f8kkegaard A, Salvesen L, Hejl AM, Starhof C, et al. Distinct autoimmune anti-\u03b1-synuclein antibody patterns in multiple system atrophy and Parkinson\u2019s disease. Front Immunol. 2019;10: 2253.","journal-title":"Front Immunol"},{"issue":"1","key":"506_CR163","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00401-018-1919-7","volume":"137","author":"CD Hughes","year":"2019","unstructured":"Hughes CD, Choi ML, Ryten M, Hopkins L, Drews A, Bot\u00eda JA, et al. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis. Acta Neuropathol. 2019;137(1):121.","journal-title":"Acta Neuropathol"},{"key":"506_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebri\u00e1n","year":"2014","unstructured":"Cebri\u00e1n C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5: 3633.","journal-title":"Nat Commun"},{"issue":"23","key":"506_CR165","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, et al. MHCII is required for \u03b1-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33(23):9592\u2013600.","journal-title":"J Neurosci"},{"issue":"3","key":"506_CR166","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/glia.22935","volume":"64","author":"HL Martin","year":"2016","unstructured":"Martin HL, Santoro M, Mustafa S, Riedel G, Forrester JV, Teismann P. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson\u2019s disease. Glia. 2016;64(3):386\u201395.","journal-title":"Glia"},{"issue":"4","key":"506_CR167","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JA Saunders","year":"2012","unstructured":"Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, et al. CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol. 2012;7(4):927\u201338.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"506_CR168","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation. 2018;15(1):205.","journal-title":"J Neuroinflammation"},{"issue":"25","key":"506_CR169","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1073\/pnas.0400569101","volume":"101","author":"EJ Benner","year":"2004","unstructured":"Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(25):9435\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"506_CR170","doi-asserted-by":"crossref","unstructured":"Post-translational glycosylation diminishes \u03b1-synuclein pathology formation. Nature Chem. Biology. 2024;20(5):553-4","DOI":"10.1038\/s41589-024-01553-0"},{"issue":"1","key":"506_CR171","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2013.168","volume":"24","author":"Y Feng","year":"2014","unstructured":"Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24(1):24\u201341.","journal-title":"Cell Res"},{"key":"506_CR172","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.redox.2015.01.003","volume":"4","author":"J Zhang","year":"2015","unstructured":"Zhang J. Teaching the basics of autophagy and mitophagy to redox biologists\u2013mechanisms and experimental approaches. Redox Biol. 2015;4:242\u201359.","journal-title":"Redox Biol"},{"issue":"1","key":"506_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0311-1","volume":"10","author":"WY Wani","year":"2017","unstructured":"Wani WY, Ouyang X, Benavides GA, Redmann M, Cofield SS, Shacka JJ, et al. O-GlcNAc regulation of autophagy and \u03b1-synuclein homeostasis; implications for Parkinson\u2019s disease. Mol Brain. 2017;10(1): 32.","journal-title":"Mol Brain"},{"issue":"13","key":"506_CR174","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1074\/jbc.M010420200","volume":"276","author":"Y Gao","year":"2001","unstructured":"Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem. 2001;276(13):9838\u201345.","journal-title":"J Biol Chem"},{"issue":"3","key":"506_CR175","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-007-9123-5","volume":"9","author":"N F\u00fcl\u00f6p","year":"2008","unstructured":"F\u00fcl\u00f6p N, Feng W, Xing D, He K, N\u0151t LG, Brocks CA, et al. Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology. 2008;9(3): 139.","journal-title":"Biogerontology"},{"issue":"2","key":"506_CR176","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0006-8993(02)04158-6","volume":"966","author":"Y Akimoto","year":"2003","unstructured":"Akimoto Y, Comer FI, Cole RN, Kudo A, Kawakami H, Hirano H, et al. Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex. Brain Res. 2003;966(2):194\u2013205.","journal-title":"Brain Res"},{"issue":"5","key":"506_CR177","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1046\/j.1471-4159.2001.00655.x","volume":"79","author":"RN Cole","year":"2001","unstructured":"Cole RN, Hart GW. Cytosolic O-glycosylation is abundant in nerve terminals. J Neurochem. 2001;79(5):1080\u20139.","journal-title":"J Neurochem"},{"issue":"Pt 7","key":"506_CR178","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/brain\/awp099","volume":"132","author":"F Liu","year":"2009","unstructured":"Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease. Brain. 2009;132(Pt 7):1820\u201332.","journal-title":"Brain"},{"issue":"3","key":"506_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.410","volume":"7","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Ryu JM, Jung YH, Lee KH, Kim DI, Han HJ. Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation. Cell Death Dis. 2016;7(3): e2158.","journal-title":"Cell Death Dis"},{"issue":"3","key":"506_CR180","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011;42(3):360\u20137.","journal-title":"Neurobiol Dis"},{"issue":"31","key":"506_CR181","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 2009;106(31):13010\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"506_CR182","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstr\u00f6m AL, Steiner JA, Pieri L, Paul G, et al. \u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest. 2011;121(2):715\u201325.","journal-title":"J Clin Invest"},{"key":"506_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012;7: 42.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"506_CR184","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.7150\/thno.54004","volume":"11","author":"C Noonin","year":"2021","unstructured":"Noonin C, Thongboonkerd V. Exosome-inflammasome crosstalk and their roles in inflammatory responses. Theranostics. 2021;11(9):4436\u201351.","journal-title":"Theranostics"},{"issue":"9","key":"506_CR185","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","volume":"7","author":"D Franciotta","year":"2008","unstructured":"Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008;7(9):852\u20138.","journal-title":"Lancet Neurol"},{"issue":"6","key":"506_CR186","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/art.27414","volume":"62","author":"HU Scherer","year":"2010","unstructured":"Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, Wang J, et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 2010;62(6):1620\u20139.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"506_CR187","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/exd.12171","volume":"22","author":"M Collin","year":"2013","unstructured":"Collin M, Ehlers M. The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. Exp Dermatol. 2013;22(8):511\u20134.","journal-title":"Exp Dermatol"},{"key":"506_CR188","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","volume":"8","author":"B Peschke","year":"2017","unstructured":"Peschke B, Keller CW, Weber P, Quast I, L\u00fcnemann JD. Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front Immunol. 2017;8:646.","journal-title":"Front Immunol"},{"issue":"9","key":"506_CR189","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.2862","volume":"18","author":"CM Karsten","year":"2012","unstructured":"Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc\u03b3RIIB and dectin-1. Nat Med. 2012;18(9):1401\u20136.","journal-title":"Nat Med"},{"issue":"5787","key":"506_CR190","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670\u20133.","journal-title":"Science"},{"issue":"11","key":"506_CR191","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.7150\/thno.53961","volume":"11","author":"D Li","year":"2021","unstructured":"Li D, Lou Y, Zhang Y, Liu S, Li J, Tao J. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Theranostics. 2021;11(11):5430\u201346.","journal-title":"Theranostics"},{"issue":"1","key":"506_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13845-8","volume":"7","author":"Y Sakae","year":"2017","unstructured":"Sakae Y, Satoh T, Yagi H, Yanaka S, Yamaguchi T, Isoda Y, et al. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fc\u03b3 receptor IIIa. Sci Rep. 2017;7(1): 13780.","journal-title":"Sci Rep"},{"issue":"10","key":"506_CR193","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/biomedicines8100410","volume":"8","author":"A Cvetko","year":"2020","unstructured":"Cvetko A, Kifer D, Gornik O, Klari\u0107 L, Visser E, Lauc G, et al. Glycosylation alterations in multiple sclerosis show increased proinflammatory potential. Biomedicines.\u00a02020;8(10):410.","journal-title":"Biomedicines"},{"issue":"3","key":"506_CR194","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.molimm.2012.01.001","volume":"50","author":"JR Gasdaska","year":"2012","unstructured":"Gasdaska JR, Sherwood S, Regan JT, Dickey LF. An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab. Mol Immunol. 2012;50(3):134\u201341.","journal-title":"Mol Immunol"},{"issue":"49","key":"506_CR195","doi-asserted-by":"publisher","first-page":"18697","DOI":"10.1073\/pnas.0607283103","volume":"103","author":"E Urich","year":"2006","unstructured":"Urich E, Gutcher I, Prinz M, Becher B. Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proc Natl Acad Sci U S A. 2006;103(49):18697\u2013702.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"506_CR196","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","volume":"1","author":"R Malhotra","year":"1995","unstructured":"Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995;1(3):237\u201343.","journal-title":"Nat Med"},{"issue":"1","key":"506_CR197","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12974-016-0611-x","volume":"13","author":"LM Watkins","year":"2016","unstructured":"Watkins LM, Neal JW, Loveless S, Michailidou I, Ramaglia V, Rees MI, et al. Complement is activated in progressive multiple sclerosis cortical grey matter lesions. J Neuroinflammation. 2016;13(1):161.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"506_CR198","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/prca.200900150","volume":"4","author":"A Sarrats","year":"2010","unstructured":"Sarrats A, Saldova R, Pla E, Fort E, Harvey DJ, Struwe WB, et al. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl. 2010;4(4):432\u201348.","journal-title":"Proteomics Clin Appl"},{"issue":"12","key":"506_CR199","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/glycob\/cwu101","volume":"24","author":"RD Wright","year":"2014","unstructured":"Wright RD, Cooper D. Glycobiology of leukocyte trafficking in inflammation. Glycobiology. 2014;24(12):1242\u201351.","journal-title":"Glycobiology"},{"issue":"4","key":"506_CR200","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/archneur.57.4.546","volume":"57","author":"I Elovaara","year":"2000","unstructured":"Elovaara I, Ukkonen M, Lepp\u00e4kynn\u00e4s M, Lehtim\u00e4ki T, Luomala M, Peltola J, et al. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Arch Neurol. 2000;57(4):546\u201351.","journal-title":"Arch Neurol"},{"issue":"1","key":"506_CR201","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ana.410370111","volume":"37","author":"P Dore-Duffy","year":"1995","unstructured":"Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol. 1995;37(1):55\u201362.","journal-title":"Ann Neurol"},{"issue":"6821","key":"506_CR202","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/35055582","volume":"409","author":"M Demetriou","year":"2001","unstructured":"Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 2001;409(6821):733\u20139.","journal-title":"Nature"},{"key":"506_CR203","doi-asserted-by":"crossref","unstructured":"Araujo L, Khim P, Mkhikian H, Mortales CL, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. Elife. 2017;6.","DOI":"10.7554\/eLife.21330"},{"issue":"48","key":"506_CR204","doi-asserted-by":"publisher","first-page":"35361","DOI":"10.1074\/jbc.M706923200","volume":"282","author":"IJ Chen","year":"2007","unstructured":"Chen IJ, Chen HL, Demetriou M. Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling. J Biol Chem. 2007;282(48):35361\u201372.","journal-title":"J Biol Chem"},{"issue":"3","key":"506_CR205","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s43587-022-00187-y","volume":"2","author":"H Mkhikian","year":"2022","unstructured":"Mkhikian H, Hayama KL, Khachikyan K, Li C, Zhou RW, Pawling J, et al. Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branching. Nat Aging. 2022;2(3):231\u201342.","journal-title":"Nat Aging"},{"issue":"12","key":"506_CR206","doi-asserted-by":"publisher","first-page":"7200","DOI":"10.4049\/jimmunol.173.12.7200","volume":"173","author":"R Morgan","year":"2004","unstructured":"Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. N-acetylglucosaminyltransferase V (Mgat5)-mediated n-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol. 2004;173(12):7200\u20138.","journal-title":"J Immunol"},{"issue":"8","key":"506_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101380","volume":"23","author":"CL Mortales","year":"2020","unstructured":"Mortales CL, Lee SU, Manousadjian A, Hayama KL, Demetriou M. N-glycan branching decouples B cell innate and adaptive immunity to control inflammatory demyelination. iScience. 2020;23(8): 101380.","journal-title":"iScience"},{"issue":"51","key":"506_CR208","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1074\/jbc.RA120.015595","volume":"295","author":"M Sy","year":"2020","unstructured":"Sy M, Brandt AU, Lee SU, Newton BL, Pawling J, Golzar A, et al. N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation. J Biol Chem. 2020;295(51):17413\u201324.","journal-title":"J Biol Chem"},{"issue":"11","key":"506_CR209","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/cdd.2011.40","volume":"18","author":"LA Pasquini","year":"2011","unstructured":"Pasquini LA, Millet V, Hoyos HC, Giannoni JP, Croci DO, Marder M, et al. Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. Cell Death Differ. 2011;18(11):1746\u201356.","journal-title":"Cell Death Differ"},{"issue":"6","key":"506_CR210","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/glycob\/cwh069","volume":"14","author":"Z Ye","year":"2004","unstructured":"Ye Z, Marth JD. N-glycan branching requirement in neuronal and postnatal viability. Glycobiology. 2004;14(6):547\u201358.","journal-title":"Glycobiology"},{"issue":"11","key":"506_CR211","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617\u201328.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"506_CR212","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jnr.10271","volume":"69","author":"HA Mohamed","year":"2002","unstructured":"Mohamed HA, Mosier DR, Zou LL, Sikl\u00f3s L, Alexianu ME, Engelhardt JI, et al. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J Neurosci Res. 2002;69(1):110\u20136.","journal-title":"J Neurosci Res"},{"issue":"6","key":"506_CR213","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ana.410360608","volume":"36","author":"ME Alexianu","year":"1994","unstructured":"Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36(6):846\u201358.","journal-title":"Ann Neurol"},{"issue":"1","key":"506_CR214","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1471-4159.2005.03184.x","volume":"94","author":"M Demestre","year":"2005","unstructured":"Demestre M, Pullen A, Orrell RW, Orth M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem. 2005;94(1):268\u201375.","journal-title":"J Neurochem"},{"issue":"6","key":"506_CR215","first-page":"368","volume":"3","author":"SH Appel","year":"1995","unstructured":"Appel SH, Smith RG, Alexianu M, Siklos L, Engelhardt J, Colom LV, et al. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci. 1995;3(6):368\u201374.","journal-title":"Clin Neurosci"},{"issue":"Suppl","key":"506_CR216","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0022-510X(94)90171-6","volume":"124","author":"SH Appel","year":"1994","unstructured":"Appel SH, Smith RG, Engelhardt JI, Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(Suppl):14\u20139.","journal-title":"J Neurol Sci"},{"issue":"5","key":"506_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035772","volume":"7","author":"M Edri-Brami","year":"2012","unstructured":"Edri-Brami M, Rosental B, Hayoun D, Welt M, Rosen H, Wirguin I, et al. Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells. PLoS One. 2012;7(5): e35772.","journal-title":"PLoS One"},{"issue":"8","key":"506_CR218","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s12035-019-1482-9","volume":"56","author":"J Costa","year":"2019","unstructured":"Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, et al. Exploring cerebrospinal fluid IgG N-glycosylation as potential biomarker for amyotrophic lateral sclerosis. Mol Neurobiol. 2019;56(8):5729\u201339.","journal-title":"Mol Neurobiol"},{"issue":"23","key":"506_CR219","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.4103\/0366-6999.194656","volume":"129","author":"J Yan","year":"2016","unstructured":"Yan J, Xu Y, Zhang L, Zhao H, Jin L, Liu WG, et al. Increased expressions of plasma galectin-3 in patients with amyotrophic lateral sclerosis. Chin Med J (Engl). 2016;129(23):2797\u2013803.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"506_CR220","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1021\/acs.jproteome.4c00010","volume":"23","author":"EM Humphries","year":"2024","unstructured":"Humphries EM, Xavier D, Ashman K, Hains PG, Robinson PJ. High-throughput proteomics and phosphoproteomics of rat tissues using microflow Zeno SWATH. J Proteome Res. 2024;23(7):2355\u201366.","journal-title":"J Proteome Res"},{"issue":"1","key":"506_CR221","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1038\/s41467-025-57916-1","volume":"16","author":"S Jager","year":"2025","unstructured":"Jager S, Zeller M, Pashkova A, Schulte D, Damoc E, Reiding KR, et al. In-depth plasma N-glycoproteome profiling using narrow-window data-independent acquisition on the Orbitrap Astral mass spectrometer. Nat Commun. 2025;16(1):2497.","journal-title":"Nat Commun"},{"issue":"9","key":"506_CR222","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41592-019-0504-x","volume":"16","author":"Z Ye","year":"2019","unstructured":"Ye Z, Mao Y, Clausen H, Vakhrushev SY. Glyco-DIA: a method for quantitative O-glycoproteomics with in silico-boosted glycopeptide libraries. Nat Methods. 2019;16(9):902\u201310.","journal-title":"Nat Methods"},{"issue":"1","key":"506_CR223","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1038\/s41467-021-26246-3","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yan G, Kong S, Wu M, Yang P, Cao W, et al. GproDIA enables data-independent acquisition glycoproteomics with comprehensive statistical control. Nat Commun. 2021;12(1):6073.","journal-title":"Nat Commun"},{"issue":"11","key":"506_CR224","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrmicro1530","volume":"4","author":"J Stevens","year":"2006","unstructured":"Stevens J, Blixt O, Paulson JC, Wilson IA. Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol. 2006;4(11):857\u201364.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"506_CR225","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nbt0909-797","volume":"27","author":"RA Childs","year":"2009","unstructured":"Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol. 2009;27(9):797\u20139.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"506_CR226","first-page":"285","volume":"9","author":"K Dang","year":"2020","unstructured":"Dang K, Zhang W, Jiang S, Lin X, Qian A. Application of lectin microarrays for biomarker discovery. Chem Open. 2020;9(3):285\u2013300.","journal-title":"Chem Open"},{"issue":"7\u20138","key":"506_CR227","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/prca.201200014","volume":"6","author":"BB Haab","year":"2012","unstructured":"Haab BB. Using lectins in biomarker research: addressing the limitations of sensitivity and availability. Proteomics Clin Appl. 2012;6(7\u20138):346\u201350.","journal-title":"Proteomics Clin Appl"},{"issue":"3","key":"506_CR228","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41592-024-02558-2","volume":"22","author":"Z Ye","year":"2025","unstructured":"Ye Z, Sabatier P, van der Hoeven L, Lechner MY, Phlairaharn T, Guzman UH, et al. Enhanced sensitivity and scalability with a Chip-Tip workflow enables deep single-cell proteomics. Nat Methods. 2025;22(3):499\u2013509.","journal-title":"Nat Methods"},{"issue":"3","key":"506_CR229","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","volume":"61","author":"F Prati","year":"2018","unstructured":"Prati F, Bottegoni G, Bolognesi ML, Cavalli A. BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for alzheimer\u2019s disease. J Med Chem. 2018;61(3):619\u201337.","journal-title":"J Med Chem"},{"issue":"5","key":"506_CR230","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/med.21434","volume":"37","author":"SO Bachurin","year":"2017","unstructured":"Bachurin SO, Bovina EV, Ustyugov AA. Drugs in clinical trials for Alzheimer\u2019s disease: the major trends. Med Res Rev. 2017;37(5):1186\u2013225.","journal-title":"Med Res Rev"},{"issue":"5","key":"506_CR231","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","volume":"36","author":"M Zheng","year":"2018","unstructured":"Zheng M, Tao W, Zou Y, Farokhzad OC, Shi B. Nanotechnology-based strategies for siRNA brain delivery for disease therapy. Trends Biotechnol. 2018;36(5):562\u201375.","journal-title":"Trends Biotechnol"},{"issue":"10","key":"506_CR232","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nn1531","volume":"8","author":"O Singer","year":"2005","unstructured":"Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005;8(10):1343\u20139.","journal-title":"Nat Neurosci"},{"key":"506_CR233","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D, et al. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv. 2020;6(41).","DOI":"10.1126\/sciadv.abc7031"},{"issue":"4","key":"506_CR234","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"506_CR235","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0254-6272(13)60180-6","volume":"33","author":"Y Diwu","year":"2013","unstructured":"Diwu Y, Tian J, Shi J. Effect of xixin decoction on O-linked N-acetylglucosamine glycosylation of tau proteins in rat brain with sporadic Alzheimer disease. J Tradit Chin Med. 2013;33(3):367\u201372.","journal-title":"J Tradit Chin Med"},{"issue":"9","key":"506_CR236","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409105","volume":"12","author":"C Liang","year":"2025","unstructured":"Liang C, Yuan Z, Yang S, Zhu Y, Chen Z, Can D, et al. Mannose promotes \u03b2-amyloid pathology by regulating BACE1 glycosylation in Alzheimer\u2019s disease. Adv Sci. 2025;12(9): e2409105.","journal-title":"Adv Sci"},{"issue":"1","key":"506_CR237","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-023-02893-9","volume":"20","author":"M Sy","year":"2023","unstructured":"Sy M, Newton BL, Pawling J, Hayama KL, Cordon A, Yu Z, et al. N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial. J Neuroinflammation. 2023;20(1):209.","journal-title":"J Neuroinflammation"},{"key":"506_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107133","volume":"202","author":"Y Wang","year":"2024","unstructured":"Wang Y, Du Y, Huang H, Cao Y, Pan K, Zhou Y, et al. Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer\u2019s disease. Pharmacol Res. 2024;202: 107133.","journal-title":"Pharmacol Res"},{"key":"506_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107133","volume":"202","author":"Y Wang","year":"2024","unstructured":"Wang Y, Du Y, Huang H, Cao Y, Pan K, Zhou Y, et al. Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer\u2019s disease. Pharmacol Res. 2024;202: 107133.","journal-title":"Pharmacol Res"},{"issue":"12","key":"506_CR240","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y, Hu H, Yang N, Kong X, et al. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy. 2020;16(12):2193\u2013205.","journal-title":"Autophagy"},{"issue":"2","key":"506_CR241","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9(2):197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"506_CR242","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-016-0181-2","volume":"8","author":"V Logovinsky","year":"2016","unstructured":"Logovinsky V, Satlin A, Lai R, Swanson C, Kaplow J, Osswald G, et al. Safety and tolerability of BAN2401 - a clinical study in Alzheimer\u2019s disease with a protofibril selective A\u03b2 antibody. Alzheimers Res Ther. 2016;8(1):14.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"506_CR243","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","volume":"76","author":"RB DeMattos","year":"2012","unstructured":"DeMattos RB, Lu J, Tang Y, Racke Margaret M, DeLong CA, Tzaferis John A, et al. A plaque-specific antibody clears existing \u03b2-amyloid plaques in Alzheimer\u2019s disease mice. Neuron. 2012;76(5):908\u201320.","journal-title":"Neuron"},{"issue":"3","key":"506_CR244","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","volume":"13","author":"I Schwab","year":"2013","unstructured":"Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13(3):176\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"506_CR245","doi-asserted-by":"publisher","first-page":"581","DOI":"10.14283\/jpad.2023.56","volume":"10","author":"Z Fei","year":"2023","unstructured":"Fei Z, Pan B, Pei R, Ye S, Wang Z, Ma L, et al. Neuroprotective effects of IVIG against Alzheimer\u2019 s disease via regulation of antigen processing and presentation by MHC class I molecules in 3xTg-AD mice. J Prev Alzheimers Dis. 2023;10(3):581\u201394.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"506_CR246","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13643-022-02115-y","volume":"11","author":"Z Fei","year":"2022","unstructured":"Fei Z, Pan B, Pei R, Chen Z, Du X, Cao H, et al. Efficacy and safety of blood derivatives therapy in Alzheimer\u2019s disease: a systematic review and meta-analysis. Syst Rev. 2022;11(1):256.","journal-title":"Syst Rev"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00506-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-025-00506-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00506-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:03:18Z","timestamp":1758574998000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-025-00506-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":246,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1186\/s40035-025-00506-4","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}